Home / Health / US Obesity Crisis: Regional Disparities Persist
US Obesity Crisis: Regional Disparities Persist
6 Aug
Summary
- Thirty-nine states reported obesity rates above 30% in 2023.
- GLP-1 drug usage has nearly quadrupled since 2024.
- Obesity rates vary significantly by geography and systemic factors.
As of 2023, thirty-nine U.S. states reported age-adjusted obesity rates surpassing 30%, with three states reaching critical levels of 40% or higher. The national obesity rate stood at 34.2% in 2024, the most recent year with available state-level data.
Breakthrough GLP-1 drugs, including Ozempic and Wegovy, are now common tools in combating obesity. Their usage rates have nearly quadrupled since 2024, coinciding with a notable decrease in the overall national obesity rate. Despite this progress, these medications are not universally accessible, and obesity continues to be a significant public health concern.
The prevalence of obesity exhibits considerable geographic variation across the United States. Regional disparities are shaped by systemic factors such as income, education levels, access to healthy food options, urban design that encourages physical activity, and local public health investments. The U.S. News Best States rankings for 2026 incorporated obesity rates, derived from CDC data, into their Public Health and Healthcare category scores.
